NEW YORK, April 3, 2013 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies investors of Obagi Medical Products, Inc. ("Obagi" or the "Company") (Nasdaq:OMPI) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to Valeant Pharmaceuticals International, Inc. (NYSE:VRX) .
Sign-up for 2013/4/3 - SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Obagi Medical Products, Inc. in Connection With the Sale of the Company to Valeant Pharmaceuticals International, Inc. -- OMPI investment picks